Cash Equivalents - Edwards Lifesciences Corp (NYSE:EW) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 87.04 USD -1.07%

Updated:

Edwards Lifesciences Corp
Cash Equivalents

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Edwards Lifesciences Corp
Cash Equivalents Peer Comparison

BDX

BSX

SYK

ABT

ISRG

Company		Cash Equivalents	CAGR 3Y	CAGR 5Y	CAGR 10Y
	Edwards Lifesciences Corp NYSE:EW	Cash Equivalents $1.2B	CAGR 3-Years 1%	CAGR 5-Years 12%	CAGR 10-Years 15%
	Becton Dickinson and Co NYSE:BDX	Cash Equivalents $2.3B	CAGR 3-Years -14%	CAGR 5-Years 28%	CAGR 10-Years 3%
	Boston Scientific Corp NYSE:BSX	Cash Equivalents $2.3B	CAGR 3-Years 5%	CAGR 5-Years 76%	CAGR 10-Years 28%
	Stryker Corp NYSE:SYK	Cash Equivalents $2.3B	CAGR 3-Years 1%	CAGR 5-Years 7%	CAGR 10-Years 5%
	Abbott Laboratories NYSE:ABT	Cash Equivalents $6.3B	CAGR 3-Years -8%	CAGR 5-Years 16%	CAGR 10-Years 12%
	Intuitive Surgical Inc NASDAQ:ISRG	Cash Equivalents $2.2B	CAGR 3-Years 39%	CAGR 5-Years 29%	CAGR 10-Years 11%

See Also

Based on the financial report for Mar 31, 2024, Edwards Lifesciences Corp's Cash Equivalents amounts to 1.2B USD.

Over the last year, the Cash Equivalents growth was 40%. The average annual Cash Equivalents growth rates for Edwards Lifesciences Corp have been 1% over the past three years , 12% over the past five years , and 15% over the past ten years .

Join more than 141,600+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.